An alternate method for nasal medicine delivery is in-situ gel

Authors

  • Sumit Sinha Mahapatra Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, East Sikkim 737136
  • Arif Mahammad Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, East Sikkim 737136
  • Sanjib Bahadur Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, East Sikkim 737136
  • Pragya Baghel Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, East Sikkim 737136

DOI:

https://doi.org/10.61114/UJPSR.8.2.2022.8-12

Keywords:

Intranasal, GIT, Orally, Uncomfortable

Abstract

Nasal medication administration has been used for therapeutic and recreational purposes since the dawn of civilization. The importance of and interest in the systemic effects of medications taken orally has grown over the past few decades. Medications administered intra-nasally provide an intriguing option to the parenteral route, which can occasionally be uncomfortable. These might involve avoiding pre-systemic release in the digestive tract and eliminating the first-pass effect (GIT), necessitating the use of a tiny dose of a specific medicine. Lowering the dose will lessen the negative effects and, ultimately, lower the cost of the medication. The likelihood for intranasal medication delivery to overcome certain significant drawbacks is linked with the other stated routes making it the most exciting path for drug administration. This review covered how in situ gel became more popular than previous nasal administration forms.

References

Behl CR, Pimplaskar HK, Sileno AP, DeMeireles J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 1998;29:89–116. https://doi.org/10.1016/S0169-409X(97)00063-X.

Kaur P, Garg T, Rath G, Goyal AK. In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane. Artif Cells, Nanomedicine Biotechnol 2016;44:1167–76. https://doi.org/10.3109/21691401.2015.1012260.

Ban MM, Chakote VR, Dhembre GN, Rajguru JR, Joshi DA. in-Situ Gel for Nasal Drug Delivery Original Research Article in-Situ Gel for Nasal Drug Delivery 2018;08:18763–9.

Bhandwalkar MJ, Inamdar IK, Kalbhare SB, Abhishek D, Mandrupkar SN. ( An International Multidisciplinary Peer Review Open Access monthly Journal ) W A review on in situ Nasal Gels for Nasal drug delivery system 2020;3:1062–73.

Med I, Medica EE, Abstracts IP, Abstracts C. Indian Journal of Pharmaceutical Sciences Scienti fi c Publication of the Indian Pharmaceutical Association Recent Trends in Drug-Likeness Prediction : A Comprehensive Aqua Triggered In Situ Gelling Microemulsion for Nasal Delivery 2007;69:2007–9.

B. H, M. K, B. Sree R, A. V, K. P. An Overview on Nasal Drug Delivery System. Asian J Pharm Res 2022:249–58. https://doi.org/10.52711/2231-5691.2022.00041.

Anjali S, Abhijeet K, Ajay S. Nasal In Situ Gel : Novel Approach for Nasal Drug Delivery. J Drug Deliv Ther 2020;10:183–97.

Rahisuddin, Sharma PK, Garg G, Salim M. Review on nasal drug delivery system with recent advancemnt. Int J Pharm Pharm Sci 2011;3:6–11.

Krishnamoorthy R, Mitra AK. Prodrugs for nasal drug delivery. Adv Drug Deliv Rev 1998;29:135–46. https://doi.org/10.1016/S0169-409X(97)00065-3.

Mayor SH, Illum L. Investigation of the effect of anaesthesia on nasal absorption of insulin in rats. Int J Pharm 1997;149:123–9. https://doi.org/10.1016/S0378-5173(96)04858-2.

Nimi T, Manohar D. An Overview on In-Situ Nasal Gel for Drug Delivery. J Pharm Sci Res 2019;11:2585–9.

Karavasili C, Fatouros DG. Smart materials: In situ gel-forming systems for nasal delivery. Drug Discov Today 2016;21:157–66. https://doi.org/10.1016/j.drudis.2015.10.016.

Illum L, Fisher AN, Jabbal-Gill I, Davis SS. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm 2001;222:109–19. https://doi.org/10.1016/S0378-5173(01)00708-6.

Pontiroli AE, Alberetto M, Calderara A, Pajetta E, Pozza G. Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents. Eur J Clin Pharmacol 1989;37:427–30. https://doi.org/10.1007/BF00558516.

Talegaonkar S, Mishra PR. Intranasal delivery: An approach to bypass the blood brain barrier. Indian J Pharmacol 2004;36:140–7.

Conway MR, Muhammad BR;, Mahdi UH, Mohammed H, Smith AM, Conway BR. Nasal Drug Delivery Systems: An Overview Original Citation Ghori. Am J Pharmacol Sci 2015;3:110–9. https://doi.org/10.12691/ajps-3-5-2.

Aikawa K, Matsumoto K, Uda H, Tanaka S, Shimamura H, Aramaki Y, et al. Prolonged release of drug from O/w emulsion and residence in rat nasal cavity. Pharm Dev Technol 1998;3:461–9. https://doi.org/10.3109/10837459809028627.

Kararli TT, Needham TE, Griffin M, Schoenhard G, Ferro LJ, Alcorn L. Oral Delivery of a Renin Inhibitor Compound Using Emulsion Formulations. Pharm Res An Off J Am Assoc Pharm Sci 1992;9:888–93. https://doi.org/10.1023/A:1015896731545.

Kararli TT, Needham TE, Schoenhard G, Baron DA, Schmidt RE, Katz B, et al. Enhancement of Nasal Delivery of a Renin Inhibitor in the Rat Using Emulsion Formulations. Pharm Res An Off J Am Assoc Pharm Sci 1992;9:1024–8. https://doi.org/10.1023/A:1015850310589.

Mitra AK. Bile Salt - Fatty Acid-Mixed Micelles as Nasal Absorption Promoters of Peptides I - Effects of Counterions, Adjuvant Composition of Lipid Structure on the Nasal Absorption of [D-Arj2]-Kyotorphin. Pharm Res 1990;7:127–33.

Law SL, Shih CL. Characterization of calcitonin-containing liposome formulations for intranasal delivery. J Microencapsul 2001;18:211–21. https://doi.org/10.1080/02652040010000334.

Illum L, Jørgensen H, Bisgaard H, Krogsgaard O, Rossing N. Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm 1987;39:189–99. https://doi.org/10.1016/0378-5173(87)90216-X.

Illum L, Farraj NF, Davis SS, Johansen BR, O’Hagan DT. Investigation of the nasal absorption of biosynthetic human growth hormone in sheep-use of a bioadhesive microsphere delivery system. Int J Pharm 1990;63:207–11. https://doi.org/10.1016/0378-5173(90)90126-O.

Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res 2011;2:215–22. https://doi.org/10.4103/2231-4040.90876.

Nakamura K, Tanaka Y, Sakurai M. Dynamic mechanical properties of aqueous gellan solutions in the sol-gel transition region. Carbohydr Polym 1996;30:101–8. https://doi.org/10.1016/S0144-8617(96)00081-1.

Mahdi MH, Conway BR, Smith AM. Development of mucoadhesive sprayable gellan gum fluid gels. Int J Pharm 2015;488:12–9. https://doi.org/10.1016/j.ijpharm.2015.04.011.

Sworn G, Sanderson GR, Gibson W. Gellan gum fluid gels. Top Catal 1995;9:265–71. https://doi.org/10.1016/S0268-005X(09)80257-9.

Nirmal HB, Bakliwal SR, Pawar SP. In-Situ gel: New trends in controlled and sustained drug delivery system. Int J PharmTech Res 2010;2:1398–408.

Devi R, Chaudhary A, Pandit V. Mucoadhesive insitu nasal gel-A novel approach. J Adv Drug Deliv 2014;1.

Nair SC, John MS, Anoop KR. In Situ Gel : An Innovative Approach for Safe and Sustained Nasal Drug Delivery 2014;24:1–7.

Gupta S, Archana ,, Niranjan AK. A Comprehensive Review on In-Situ Gel Drug Delivery System. J Drug Deliv Ther 2022;12:245–8. https://doi.org/10.22270/jddt.v12i4-s.5539.

Downloads

Published

31-12-2022

How to Cite

Mahapatra, S. S., Mahammad, A., Bahadur, S., & Baghel, P. (2022). An alternate method for nasal medicine delivery is in-situ gel. UNIVERSAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 8(2), 8–12. https://doi.org/10.61114/UJPSR.8.2.2022.8-12

Issue

Vol. 8 No. 2 (2022)

Section

Articles

License

Copyright (c) 2023 Sumit Sinha Mahapatra, Arif Mahammad, Sanjib Bahadur, Pragya Baghel

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.